Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Not Applicable

Active, not recruiting

• Conditions: Parents
• Interventions: Behavioral: HPV Vaccine Education; Behavioral: Text Messaging Reminder

• Registration Number: NCT03209713
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans.

The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection.

A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-28
• Study First Submitted: 2017-07-03
• Study First Submitted QC: 2017-07-03
• Study First Posted: 2017-07-06
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-16
• Last Update Posted: 2024-04-17
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 672

Inclusion Criteria

• Born in Mexico or born in U.S. but self-describes as Mexican-American
• Spanish is his or her primary language
• Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe)
• Self-identifies as the child's main caregiver
• Currently owns a cell phone and uses text messaging services and is willing to accept text messages for this study
• 21 to 84 years old

Read More

Exclusion Criteria

• Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Parental Education + Text Messaging	HPV Vaccine Education	Participants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.
Parental Education + Text Messaging	Text Messaging Reminder	Participants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.
Parental Education	HPV Vaccine Education	Participants will receive parental education on HPV vaccine and the vaccine's benefits.

Primary Outcome Measures

Name	Time	Method
Vaccination completion assessment rate	2 years	Comparison rates of vaccination completion will be assessed by Fisher's exact test.

Trial Locations

Locations (4)

Research, Education and Access to Community Health (REACH); 🇺🇸 Las Vegas, Nevada, United States

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States

The University of Texas at El Paso; 🇺🇸 El Paso, Texas, United States

Alivio Medical Center; 🇺🇸 Chicago, Illinois, United States